Advertisement
Review Article| Volume 16, ISSUE 1, P107-118, March 2023

Download started.

Ok

On the Chopping Block

Overview of DICER1 Mutations in Endocrine and Neuroendocrine Neoplasms
Published:December 12, 2022DOI:https://doi.org/10.1016/j.path.2022.09.010

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgical Pathology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ameres S.L.
        • Zamore P.D.
        Diversifying microRNA sequence and function.
        Nat Rev Mol Cell Biol. 2013; 14: 475-488
        • Lin R.
        • Avery L.
        RNA interference. Policing rogue genes.
        Nature. 1999; 402: 128-129
        • Ibáñez-Ventoso C.
        • Vora M.
        • Driscoll M.
        Sequence relationships among C. elegans, D. melanogaster and human microRNAs highlight the extensive conservation of microRNAs in biology.
        PLoS One. 2008; 3: e2818
        • Hammond S.M.
        An overview of microRNAs.
        Adv Drug Deliv Rev. 2015; 87: 3-14
        • Dexheimer P.J.
        • Cochella L.
        MicroRNAs: From Mechanism to Organism.
        Front Cell Dev Biol. 2020; 8: 409
        • Wu K.
        • He J.
        • Pu W.
        • et al.
        The Role of Exportin-5 in MicroRNA Biogenesis and Cancer.
        Genomics Proteomics Bioinformatics. 2018; 16: 120-126
        • Bernstein E.
        • Caudy A.A.
        • Hammond S.M.
        • et al.
        Role for a bidentate ribonuclease in the initiation step of RNA interference.
        Nature. 2001; 409: 363-366
        • Knight S.W.
        • Bass B.L.
        A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans.
        Science. 2001; 293: 2269-2271
        • Welker N.C.
        • Maity T.S.
        • Ye X.
        • et al.
        Dicer’s helicase domain discriminates dsRNA termini to promote an altered reaction mode.
        Mol Cell. 2011; 41: 589-599
        • Takeshita D.
        • Zenno S.
        • Lee W.C.
        • et al.
        Homodimeric structure and double-stranded RNA cleavage activity of the C-terminal RNase III domain of human dicer.
        J Mol Biol. 2007; 374: 106-120
        • Ohishi K.
        • Nakano T.
        A forward genetic screen to study mammalian RNA interference: essential role of RNase IIIa domain of Dicer1 in 3’ strand cleavage of dsRNA in vivo.
        FEBS J. 2012; 279: 832-843
        • Brenneman M.
        • Field A.
        • Yang J.
        • et al.
        Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma/DICER1 syndrome: a unique variant of the two-hit tumor suppression model.
        F1000Res. 2015; 4: 214
        • Lee M.
        • Kim T.-I.
        • Jang S.J.
        • et al.
        Pleuropulmonary Blastoma with Hotspot Mutations in RNase IIIb Domain of DICER 1: Clinicopathologic Study of 10 Cases in a Single-Institute Experience.
        Pathobiology. 2021; 88: 251-260
        • Hill D.A.
        • Ivanovich J.
        • Priest J.R.
        • et al.
        DICER1 mutations in familial pleuropulmonary blastoma.
        Science. 2009; 325: 965
        • Heravi-Moussavi A.
        • Anglesio M.S.
        • Cheng S.-W.G.
        • et al.
        Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
        N Engl J Med. 2012; 366: 234-242
        • Wu M.K.
        • Sabbaghian N.
        • Xu B.
        • et al.
        Biallelic DICER1 mutations occur in Wilms tumours.
        J Pathol. 2013; 230: 154-164
        • de Kock L.
        • Wu M.K.
        • Foulkes W.D.
        Ten years of DICER1 mutations: Provenance, distribution, and associated phenotypes.
        Hum Mutat. 2019; 40: 1939-1953
        • Rio Frio T.
        • Bahubeshi A.
        • Kanellopoulou C.
        • et al.
        DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
        JAMA. 2011; 305: 68-77
        • Bahubeshi A.
        • Bal N.
        • Rio Frio T.
        • et al.
        Germline DICER1 mutations and familial cystic nephroma.
        J Med Genet. 2010; 47: 863-866
        • Doros L.
        • Yang J.
        • Dehner L.
        • et al.
        DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome.
        Pediatr Blood Cancer. 2012; 59: 558-560
        • Robertson J.C.
        • Jorcyk C.L.
        • Oxford J.T.
        DICER1 Syndrome: DICER1 Mutations in Rare Cancers.
        Cancers (Basel). 2018; 10: E143
        • Sabbaghian N.
        • Hamel N.
        • Srivastava A.
        • et al.
        Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma.
        J Med Genet. 2012; 49: 417-419
        • Juhlin C.C.
        • Stenman A.
        • Zedenius J.
        Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features.
        Histopathology. 2021; 79: 661-666
        • Seki M.
        • Yoshida K.
        • Shiraishi Y.
        • et al.
        Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.
        Cancer Res. 2014; 74: 2742-2749
        • Slade I.
        • Bacchelli C.
        • Davies H.
        • et al.
        DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.
        J Med Genet. 2011; 48: 273-278
        • Schultz K.A.
        • Yang J.
        • Doros L.
        • et al.
        DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions.
        Pathol Case Rev. 2014; 19: 90-100
        • Foulkes W.D.
        • Bahubeshi A.
        • Hamel N.
        • et al.
        Extending the phenotypes associated with DICER1 mutations.
        Hum Mutat. 2011; 32: 1381-1384
        • Choi S.
        • Lee J.S.
        • Bassim C.W.
        • et al.
        Dental abnormalities in individuals with pathogenic germline variation in DICER1.
        Am J Med Genet A. 2019; 179: 1820-1825
        • Huryn L.A.
        • Turriff A.
        • Harney L.A.
        • et al.
        DICER1 Syndrome: Characterization of the Ocular Phenotype in a Family-Based Cohort Study.
        Ophthalmology. 2019; 126: 296-304
        • Khan N.E.
        • Bauer A.J.
        • Doros L.
        • et al.
        Macrocephaly associated with the DICER1 syndrome.
        Genet Med. 2017; 19: 244-248
        • Baloch Z.W.
        • Asa S.L.
        • Barletta J.A.
        • et al.
        Overview of the 2022 WHO Classification of Thyroid Neoplasms.
        Endocr Pathol. 2022; https://doi.org/10.1007/s12022-022-09707-3
        • Rath S.R.
        • Bartley A.
        • Charles A.
        • et al.
        Multinodular Goiter in children: an important pointer to a germline DICER1 mutation.
        J Clin Endocrinol Metab. 2014; 99: 1947-1948
        • Khan N.E.
        • Bauer A.J.
        • Schultz K.A.P.
        • et al.
        Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.
        J Clin Endocrinol Metab. 2017; 102: 1614-1622
        • Altaraihi M.
        • Hansen T.
        • van O.
        • et al.
        Prevalence of Pathogenic Germline DICER1 Variants in Young Individuals Thyroidectomised Due to Goitre - A National Danish Cohort.
        Front Endocrinol (Lausanne). 2021; 12: 727970
        • de Kock L.
        • Sabbaghian N.
        • Soglio D.B.-D.
        • et al.
        Exploring the association Between DICER1 mutations and differentiated thyroid carcinoma.
        J Clin Endocrinol Metab. 2014; 99: E1072-E1077
        • Landa I.
        • Ibrahimpasic T.
        • Boucai L.
        • et al.
        Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
        J Clin Invest. 2016; 126: 1052-1066
      1. Cancer Genome Atlas Research Network Integrated genomic characterization of papillary thyroid carcinoma.
        Cell. 2014; 159: 676-690
        • Ghossein C.A.
        • Dogan S.
        • Farhat N.
        • et al.
        Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform.
        Virchows Arch. 2022; 480: 293-302
        • Satapathy S.
        • Bal C.
        Genomic landscape of sporadic pediatric differentiated thyroid cancers: a systematic review and meta-analysis.
        J Pediatr Endocrinol Metab. 2022; https://doi.org/10.1515/jpem-2021-0741
        • Rutter M.M.
        • Jha P.
        • Schultz K.A.P.
        • et al.
        DICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association.
        J Clin Endocrinol Metab. 2016; 101: 1-5
        • Bongiovanni M.
        • Sykiotis G.P.
        • La Rosa S.
        • et al.
        Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma.
        Thyroid. 2020; 30: 72-80
        • Wasserman J.D.
        • Sabbaghian N.
        • Fahiminiya S.
        • et al.
        DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma.
        J Clin Endocrinol Metab. 2018; 103: 2009-2015
        • Nicolson N.G.
        • Murtha T.D.
        • Dong W.
        • et al.
        Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology.
        J Clin Endocrinol Metab. 2018; 103: 2640-2650
        • Paulsson J.O.
        • Wang N.
        • Gao J.
        • et al.
        GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours.
        Endocr Relat Cancer. 2020; https://doi.org/10.1530/ERC-19-0446
        • Bae J.-S.
        • Jung S.-H.
        • Hirokawa M.
        • et al.
        High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid.
        Endocr Pathol. 2021; 32: 336-346
        • Poma A.M.
        • Condello V.
        • Denaro M.
        • et al.
        DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions.
        Oncotarget. 2019; 10: 1785-1797
        • Costa V.
        • Esposito R.
        • Ziviello C.
        • et al.
        New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma.
        Oncotarget. 2015; 6: 11242-11251
        • Yuan X.
        • Mu N.
        • Wang N.
        • et al.
        GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
        Oncogene. 2019; 38: 965-979
        • Chernock R.D.
        • Rivera B.
        • Borrelli N.
        • et al.
        Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations.
        Mod Pathol. 2020; https://doi.org/10.1038/s41379-020-0458-7
        • Hellgren L.S.
        • Hysek M.
        • Jatta K.
        • et al.
        Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature.
        Head Neck Pathol. 2020; https://doi.org/10.1007/s12105-020-01208-1
        • Sauer M.
        • Barletta J.A.
        Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors.
        Head Neck Pathol. 2022; 16: 190-199
        • Agaimy A.
        • Witkowski L.
        • Stoehr R.
        • et al.
        Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations-is the term “thyroblastoma” more appropriate?.
        Virchows Arch. 2020; 477: 787-798
        • Rabinowits G.
        • Barletta J.
        • Sholl L.M.
        • et al.
        Successful Management of a Patient with Malignant Thyroid Teratoma.
        Thyroid. 2017; 27: 125-128
        • Rooper L.M.
        • Bynum J.P.
        • Miller K.P.
        • et al.
        Recurrent DICER1 Hotspot Mutations in Malignant Thyroid Gland Teratomas: Molecular Characterization and Proposal for a Separate Classification.
        Am J Surg Pathol. 2020; 44: 826-833
        • Scheithauer B.W.
        • Kovacs K.
        • Horvath E.
        • et al.
        Pituitary blastoma.
        Acta Neuropathol. 2008; 116: 657-666
        • de Kock L.
        • Sabbaghian N.
        • Plourde F.
        • et al.
        Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.
        Acta Neuropathol. 2014; 128: 111-122
        • Asa S.L.
        • Mete O.
        • Perry A.
        • et al.
        Overview of the 2022 WHO Classification of Pituitary Tumors.
        Endocr Pathol. 2022; 33: 6-26
        • Solarski M.
        • Rotondo F.
        • Foulkes W.D.
        • et al.
        DICER1 gene mutations in endocrine tumors.
        Endocr Relat Cancer. 2018; 25: R197-R208
        • Greppin K.
        • Cioffi G.
        • Waite K.A.
        • et al.
        Epidemiology of pineoblastoma in the United States, 2000-2017.
        Neurooncol Pract. 2022; 9: 149-157
        • de Kock L.
        • Sabbaghian N.
        • Druker H.
        • et al.
        Germ-line and somatic DICER1 mutations in pineoblastoma.
        Acta Neuropathol. 2014; 128: 583-595
        • Juhlin C.C.
        • Erickson L.A.
        Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice.
        Endocr Pathol. 2021; 32: 17-34
        • Kang H.
        • Pettinga D.
        • Schubert A.D.
        • et al.
        Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.
        Oncologist. 2019; 24: 791-797
        • Juhlin C.C.
        • Bertherat J.
        • Giordano T.J.
        • et al.
        What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia?.
        From Histopathology Translational Genomics Endocr Pathol. 2021; 32: 102-133
        • de Sousa G.R.V.
        • Ribeiro T.C.
        • Faria A.M.
        • et al.
        Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.
        Oncotarget. 2015; 6: 22724-22733
        • Juhlin C.C.
        Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.
        Endocr Pathol. 2021; 32: 228-244
        • Buffet A.
        • Burnichon N.
        • Favier J.
        • et al.
        An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
        Best Pract Res Clin Endocrinol Metab. 2020; 34: 101416
        • Caramuta S.
        • Lee L.
        • Ozata D.M.
        • et al.
        Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma.
        Endocr Relat Cancer. 2013; 20: 551-564
        • Gao J.
        • Shi H.
        • Juhlin C.C.
        • et al.
        Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70.
        IScience. 2021; 24: 103264
        • Kumar S.
        • Xie H.
        • Shi H.
        • et al.
        Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes.
        Int J Cancer. 2020; 146: 1652-1666
        • Rivera B.
        • Nadaf J.
        • Fahiminiya S.
        • et al.
        DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis.
        J Clin Invest. 2020; 130: 1479-1490
        • Paulsson J.O.
        • Rafati N.
        • DiLorenzo S.
        • et al.
        Whole-genome sequencing of follicular thyroid carcinomas reveal recurrent mutations in microRNA processing subunit DGCR8.
        J Clin Endocrinol Metab. 2021; : dgab471https://doi.org/10.1210/clinem/dgab471
        • Paulsson J.O.
        • Backman S.
        • Wang N.
        • et al.
        Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation.
        J Pathol. 2020; 250: 183-194
        • Stenman A.
        • Yang M.
        • Paulsson J.O.
        • et al.
        Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma.
        Cancers (Basel). 2021; 13: 6340